Aging of the Hematopoietic System: Mechanisms, Consequences, and Systemic Interactions
Abstract
The aging of the hematopoietic system is central to physiological aging, with profound consequences for immune competence, tissue regeneration, and systemic health. Age-related changes manifest as altered blood cell composition, functional decline in hematopoietic stem cells (HSCs), and deterioration of the bone marrow niche. Beyond hematologic dysfunction, hematopoietic aging acts as a systemic amplifier of age-related diseases through clonal hematopoiesis and inflammatory remodeling. This review integrates recent insights into the mechanisms and systemic impacts of hematopoietic aging, reframing it as a modifiable axis of systemic aging. We highlight emerging rejuvenation strategies-senolytics, metabolic reprogramming, and microbiota-targeted therapies-that aim to restore hematopoietic and immune function, offering promising avenues to improve healthspan and reduce age-related multimorbidity.
- Microbiota-targeted therapies
- Senolytics
- Cellular senescence
- Immune response
- Inflammation
- Clonal hematopoiesis of indeterminate potential
The paper
The University of Tokyo; Fujita Health University
Aging Cell, 16 Jan 2026, Open access



